Arcutis Biotherapeutics Inc
NASDAQ: ARQT
$9.83
Closing Price on August 23, 2024
ARQT Chart and Intraday Price
ARQT Company Data
Asset Type | Stock |
Exchange | NASDAQ |
Currency | USD |
Country | USA |
Sector | LIFE SCIENCES |
Industry | PHARMACEUTICAL PREPARATIONS |
Address | 2945 TOWNSGATE ROAD, SUITE 110, WESTLAKE VILLAGE, CA, US |
Fiscal Year End | December |
Latest Quarter | 12/31/2023 |
Market Cap | 1,139.49M USD |
Shares Outstanding | 96,813,000 |
ARQT Articles
Wednesday’s top analyst upgrades and downgrades included Allegro, Jinkosolar, Masco, Micron Technology, Plug Power, Smith & Wesson and Virgin Galactic.
Published:
Thursday's top analyst upgrades and downgrades included Airbnb, CrowdStrike, DoorDash, Ford, Intuit, Lumber Liquidators, Occidental Petroleum, T-Mobile, Twilio, Uber and UBS.
Published:
Thursday's top analyst upgrades and downgrades included Arcutis Biotherapeutics, DraftKings, First Solar, InflaRx, Livent, Medtronic, NextEra Energy Partners, Roku, Snowflake and Tesla.
Published:
24/7 Wall St. tracked six new secondary offerings that were announced after the close on Tuesday, September 29, 2020.
Published: